Characteristic Value a
Gender (male/female), n 43/8
AGE (years) 46.4±12.8 (47,15-89)
Weight (kg) 60.0 ±13.1 (58,36-99)
PLT count (109/L) 85.4±70.8 (65,20-450)
ALT (U/L) 59.4±70.7 (39.5,5.7-48.6)
AST (U/L) 106.5±98.5 (78.3,15.5-737)
ALB (g/L) 32.6±4.9 (32.4,23.3-49.3)
TBIL (μmol/L) 300.6±178.4 (314,7.8-729)
DBIL (μmol/L) 205.1±124.0 (217.4,3.4-545.2)
BUN (mmol/L) 7.3±5.8 (5.4,1.3-33.7)
CLcr (mL/min)b 100.6±45.1 (94.5,17.3-231)
INR 2.38±1.2 (2.1,0.9-5.9)
PT (second) 25.6±9.9 (23.2,11.8-53.9)
PTA (%) 42.9±24.0 (35,13-117)
Ctrough (mg/L) 3.9±2.5 (3.4,0.06-14.08)
Concomitant medication (PPI) n (%) of patients
Omeprazole 8 (15.7%)
Esomeprazole 9 (17.6%)
Pantoprazole 6 (11.8%)
Lansoprazole 16 (31.4%)
Genotype distribution frequency
Ultrarapid metabolizer (UM) 1 (2.0%)
Extensive metabolizer (EM) 24 (47.1%)
Intermediate metabolizer (IM) 21 (41.1%)
Poor metabolizer(PM) Child-Pugh class (A:B:C) MELD score 5 (9.8%) 4:11:36 22.4±10.7(23.8,1-45.5)